POPS RICHARD F
Insider CIK 1126490 · XLRN Director · ALKS Director and CEO, Alkermes plc, Director · EPZM Director · NBIX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2026-05-27 | 2026-05-29 | 2,567 | — | $0 | 2,567 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-05-21 | 2026-05-21 | 3,318 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-05-21 | 2026-05-21 | 3,318 | — | $0 | 37,798 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2026-05-15 | 2026-05-18 | 15,000 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2026-05-15 | 2026-05-18 | 15,000 | $47.89 | $718.4K | 49,480 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2026-05-15 | 2026-05-18 | 15,000 | $157.65 | $2.36M | 34,480 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2026-03-02 | 2026-03-04 | 88,843 | — | $0 | 88,843 | SEC↗ |
| ALKS Alkermes plc. | A Award | 2026-02-05 | 2026-02-06 | 149,580 | — | $0 | 1,439,970 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2026-02-05 | 2026-02-06 | 62,230 | $33.55 | $2.09M | 1,377,740 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2025-05-22 | 2025-05-22 | 2,869 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2025-05-22 | 2025-05-22 | 2,869 | — | $0 | 34,480 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2025-05-21 | 2025-05-22 | 3,318 | — | $0 | 3,318 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2025-02-19 | 2025-02-20 | 293,921 | — | $0 | 293,921 | SEC↗ |
| ALKS Alkermes plc. | A Award | 2025-02-06 | 2025-02-07 | 190,640 | — | $0 | 1,370,315 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2025-02-06 | 2025-02-07 | 79,925 | $31.39 | $2.51M | 1,290,390 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2024-05-22 | 2024-05-23 | 2,869 | — | $0 | 2,869 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-05-17 | 2024-05-21 | 4,199 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-05-17 | 2024-05-21 | 2,100 | $141.84 | $297.9K | 31,611 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-05-17 | 2024-05-21 | 4,199 | — | $0 | 33,711 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-03-13 | 2024-03-15 | 23,200 | $42.76 | $992.0K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-03-13 | 2024-03-15 | 23,200 | $140.33 | $3.26M | 29,512 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-03-13 | 2024-03-15 | 23,200 | $42.76 | $992.0K | 52,712 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-03-11 | 2024-03-12 | 100 | $42.76 | $4.3K | 23,200 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-03-11 | 2024-03-12 | 100 | $140.00 | $14.0K | 29,512 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-03-11 | 2024-03-12 | 100 | $42.76 | $4.3K | 29,612 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-03-08 | 2024-03-12 | 1,700 | $42.76 | $72.7K | 23,300 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-03-08 | 2024-03-12 | 1,700 | $42.76 | $72.7K | 31,212 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-03-08 | 2024-03-12 | 1,700 | $140.05 | $238.1K | 29,512 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2024-02-26 | 2024-02-27 | 274,328 | — | $0 | 274,328 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2024-02-20 | 2024-02-22 | 15,000 | $12.98 | $194.7K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2024-02-20 | 2024-02-22 | 15,000 | $12.98 | $194.7K | 44,512 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2024-02-20 | 2024-02-22 | 15,000 | $132.47 | $1.99M | 29,512 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2024-02-08 | 2024-02-12 | 91,757 | $26.77 | $2.46M | 1,179,675 | SEC↗ |
| ALKS Alkermes plc. | A Award | 2024-02-08 | 2024-02-12 | 218,551 | — | $0 | 1,271,432 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-02-27 | 4,599 | $46.24 | $212.7K | 234,599 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-02-27 | 3,999 | $69.83 | $279.3K | 203,999 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-02-27 | 5,999 | $31.64 | $189.8K | 305,999 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-02-27 | 3,999 | $53.50 | $213.9K | 203,999 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-02-27 | 5,697 | $26.82 | $152.8K | 290,570 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-02-27 | 5,980 | $24.59 | $147.0K | 305,024 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-02-27 | 6,843 | $19.34 | $132.3K | 349,030 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-02-27 | 7,168 | $20.03 | $143.6K | 365,634 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-02-27 | 7,644 | $31.93 | $244.1K | 389,844 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-02-27 | 2,419 | $31.93 | $77.2K | 123,419 | SEC↗ |
| ALKS Alkermes plc. | J Other deriv | 2023-11-17 | 2024-02-27 | 5,899 | $65.94 | $389.0K | 300,899 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2023-05-17 | 2023-05-19 | 4,199 | — | $0 | 4,199 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2023-02-23 | 2023-02-24 | 284,873 | — | $0 | 284,873 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2023-02-21 | 2023-02-22 | 32,400 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2023-02-21 | 2023-02-22 | 14,386 | $27.77 | $399.5K | 1,052,881 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2023-02-21 | 2023-02-22 | 32,400 | — | $0 | 1,067,267 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2023-02-20 | 2023-02-22 | 53,145 | $28.07 | $1.49M | 1,034,867 | SEC↗ |
| ALKS Alkermes plc. | A Award | 2023-02-20 | 2023-02-22 | 119,713 | — | $0 | 1,088,012 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2023-01-03 | 2023-01-05 | 15,000 | $12.71 | $190.7K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-01-03 | 2023-01-05 | 15,000 | $119.20 | $1.79M | 29,512 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2023-01-03 | 2023-01-05 | 15,000 | $12.71 | $190.7K | 44,512 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2022-05-18 | 2022-05-20 | 9,724 | — | $0 | 9,724 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2022-05-09 | 2022-05-11 | 7,500 | $6.66 | $50.0K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2022-05-09 | 2022-05-11 | 7,500 | $6.66 | $50.0K | 7,500 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2022-05-09 | 2022-05-11 | 7,500 | $6.66 | $50.0K | 37,012 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-05-09 | 2022-05-11 | 7,500 | $76.29 | $572.2K | 29,512 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-05-09 | 2022-05-11 | 7,500 | $76.30 | $572.3K | 29,512 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2022-05-09 | 2022-05-11 | 7,500 | $6.66 | $50.0K | 37,012 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2022-05-06 | 2022-05-06 | 120,847 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2022-05-06 | 2022-05-06 | 120,847 | $16.55 | $2.00M | 1,062,046 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2022-05-06 | 2022-05-06 | 93,747 | $27.85 | $2.61M | 968,299 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2022-05-05 | 2022-05-06 | 329,153 | — | $0 | 120,847 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2022-05-05 | 2022-05-06 | 329,153 | $16.55 | $5.45M | 1,194,709 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2022-05-05 | 2022-05-06 | 221,222 | $27.95 | $6.18M | 973,487 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2022-05-05 | 2022-05-06 | 32,288 | $28.59 | $923.1K | 941,199 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2022-02-21 | 2022-02-23 | 32,400 | — | $0 | 32,400 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2022-02-21 | 2022-02-23 | 32,400 | — | $0 | 879,942 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2022-02-21 | 2022-02-23 | 14,386 | $25.08 | $360.8K | 865,556 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2022-02-18 | 2022-02-23 | 299,044 | — | $0 | 299,044 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2022-02-16 | 2022-02-17 | 18,125 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2022-02-16 | 2022-02-17 | 18,125 | — | $0 | 855,580 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2022-02-16 | 2022-02-17 | 8,038 | $26.79 | $215.3K | 847,542 | SEC↗ |
| ALKS Alkermes plc. | A Award | 2021-09-14 | 2021-09-16 | 81,682 | — | $0 | 873,722 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2021-09-14 | 2021-09-16 | 36,267 | $30.60 | $1.11M | 837,455 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-05-19 | 2021-05-20 | 8,833 | — | $0 | 8,833 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2021-05-18 | 2021-05-19 | 150,000 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2021-05-18 | 2021-05-19 | 150,000 | $21.90 | $3.29M | 792,040 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2021-05-18 | 2021-05-19 | 150,000 | $18.11 | $2.72M | 942,040 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2021-05-11 | 2021-05-12 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2021-05-11 | 2021-05-12 | 89,703 | $21.95 | $1.97M | 852,337 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2021-05-11 | 2021-05-12 | 60,297 | $22.30 | $1.34M | 792,040 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2021-05-11 | 2021-05-12 | 150,000 | $18.11 | $2.72M | 942,040 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2021-05-06 | 2021-05-07 | 100,000 | — | $0 | 300,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2021-05-06 | 2021-05-07 | 100,000 | $18.11 | $1.81M | 892,040 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2021-05-06 | 2021-05-07 | 100,000 | $21.79 | $2.18M | 792,040 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2021-02-22 | 2021-02-24 | 342,187 | — | $0 | 342,187 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2021-02-21 | 2021-02-23 | 32,400 | — | $0 | 64,800 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2021-02-21 | 2021-02-23 | 32,400 | — | $0 | 806,426 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2021-02-21 | 2021-02-23 | 14,386 | $19.58 | $281.7K | 792,040 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2021-02-17 | 2021-02-18 | 8,750 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2021-02-17 | 2021-02-18 | 8,750 | — | $0 | 777,895 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2021-02-17 | 2021-02-18 | 3,869 | $19.97 | $77.3K | 774,026 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2021-02-16 | 2021-02-18 | 18,125 | — | $0 | 18,125 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2021-02-16 | 2021-02-18 | 18,125 | — | $0 | 777,219 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2021-02-16 | 2021-02-18 | 8,074 | $19.79 | $159.8K | 769,145 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2020-05-29 | 2020-06-02 | 14,013 | — | $0 | 14,013 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2020-05-19 | 2020-05-21 | 6,018 | — | $0 | 6,018 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2020-05-14 | 2020-05-14 | 75,000 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2020-05-14 | 2020-05-14 | 75,000 | $15.00 | $1.13M | 759,094 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2020-05-14 | 2020-05-14 | 75,000 | $11.74 | $880.5K | 834,094 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2020-05-07 | 2020-05-07 | 50,000 | — | $0 | 75,000 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2020-05-07 | 2020-05-07 | 50,000 | $14.63 | $731.5K | 759,094 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2020-05-07 | 2020-05-07 | 50,000 | $11.74 | $587.0K | 809,094 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2020-04-02 | 2020-04-03 | 50,000 | — | $0 | 125,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2020-04-02 | 2020-04-03 | 50,000 | $11.74 | $587.0K | 809,094 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2020-04-02 | 2020-04-03 | 50,000 | $13.79 | $689.5K | 759,094 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2020-03-26 | 2020-03-26 | 75,000 | — | $0 | 175,000 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2020-03-26 | 2020-03-26 | 75,000 | $14.36 | $1.08M | 759,094 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2020-03-26 | 2020-03-26 | 75,000 | $11.74 | $880.5K | 834,094 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2020-03-19 | 2020-03-19 | 75,000 | — | $0 | 250,000 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2020-03-19 | 2020-03-19 | 10,346 | $13.42 | $138.8K | 823,748 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2020-03-19 | 2020-03-19 | 48,668 | $14.51 | $706.2K | 775,080 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2020-03-19 | 2020-03-19 | 15,986 | $15.04 | $240.4K | 759,094 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2020-03-19 | 2020-03-19 | 75,000 | $11.74 | $880.5K | 834,094 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2020-03-01 | 2020-03-03 | 17,500 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2020-03-01 | 2020-03-03 | 7,770 | $20.84 | $161.9K | 759,094 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2020-03-01 | 2020-03-03 | 17,500 | — | $0 | 766,864 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2020-02-21 | 2020-02-24 | 32,400 | — | $0 | 97,200 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2020-02-21 | 2020-02-24 | 14,386 | $20.24 | $291.2K | 749,364 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2020-02-21 | 2020-02-24 | 32,400 | — | $0 | 763,750 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2020-02-20 | 2020-02-24 | 358,466 | — | $0 | 358,466 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2020-02-17 | 2020-02-18 | 8,750 | — | $0 | 8,750 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2020-02-17 | 2020-02-18 | 8,750 | — | $0 | 735,236 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2020-02-17 | 2020-02-18 | 3,886 | $17.77 | $69.1K | 731,350 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2020-02-16 | 2020-02-18 | 18,125 | — | $0 | 36,250 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2020-02-16 | 2020-02-18 | 8,072 | $17.77 | $143.4K | 726,486 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2020-02-16 | 2020-02-18 | 18,125 | — | $0 | 734,558 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-11-14 | 2019-11-15 | 100,000 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-11-14 | 2019-11-15 | 100,000 | $9.21 | $921.0K | 816,433 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2019-11-14 | 2019-11-15 | 100,000 | $19.50 | $1.95M | 716,433 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-11-08 | 2019-11-08 | 30,205 | — | $0 | 100,000 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2019-11-08 | 2019-11-08 | 30,205 | $19.73 | $595.9K | 716,433 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-11-08 | 2019-11-08 | 30,205 | $9.21 | $278.2K | 746,638 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-11-07 | 2019-11-08 | 69,795 | — | $0 | 130,205 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2019-11-07 | 2019-11-08 | 69,795 | $19.81 | $1.38M | 716,433 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-11-07 | 2019-11-08 | 69,795 | $9.21 | $642.8K | 786,228 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-09-19 | 2019-09-23 | 100,000 | — | $0 | 200,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-09-19 | 2019-09-23 | 100,000 | $9.21 | $921.0K | 816,433 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2019-09-19 | 2019-09-23 | 100,000 | $21.54 | $2.15M | 716,433 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-09-12 | 2019-09-13 | 100,000 | — | $0 | 300,000 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2019-09-12 | 2019-09-13 | 100,000 | $22.68 | $2.27M | 716,433 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-09-12 | 2019-09-13 | 100,000 | $9.21 | $921.0K | 816,433 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-09-05 | 2019-09-06 | 100,000 | — | $0 | 400,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-09-05 | 2019-09-06 | 100,000 | $9.21 | $921.0K | 816,433 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2019-09-05 | 2019-09-06 | 100,000 | $20.18 | $2.02M | 716,433 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2019-05-31 | 2019-06-07 | 17,633 | — | $0 | 17,633 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-05-23 | 2019-05-24 | 50,000 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-05-23 | 2019-05-24 | 50,000 | $8.55 | $427.5K | 766,433 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2019-05-23 | 2019-05-24 | 50,000 | $24.22 | $1.21M | 716,433 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2019-05-22 | 2019-05-23 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-05-16 | 2019-05-24 | 60,000 | — | $0 | 50,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-05-16 | 2019-05-24 | 60,000 | $8.55 | $513.0K | 776,433 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2019-05-16 | 2019-05-24 | 60,000 | $25.42 | $1.53M | 716,433 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-03-13 | 2019-03-14 | 15,829 | — | $0 | 110,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-03-13 | 2019-03-14 | 15,829 | $8.55 | $135.3K | 732,262 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2019-03-13 | 2019-03-14 | 15,829 | $33.51 | $530.4K | 716,433 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-03-12 | 2019-03-14 | 44,171 | — | $0 | 125,829 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2019-03-12 | 2019-03-14 | 44,171 | $33.24 | $1.47M | 716,433 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-03-12 | 2019-03-14 | 44,171 | $8.55 | $377.7K | 760,604 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-03-05 | 2019-03-07 | 50,000 | — | $0 | 170,000 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2019-03-05 | 2019-03-07 | 50,000 | $33.63 | $1.68M | 716,433 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-03-05 | 2019-03-07 | 50,000 | $8.55 | $427.5K | 766,433 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-03-01 | 2019-03-04 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-03-01 | 2019-03-04 | 17,500 | — | $0 | 724,203 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2019-03-01 | 2019-03-04 | 7,770 | $34.44 | $267.6K | 716,433 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-02-26 | 2019-02-27 | 10,000 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-02-26 | 2019-02-27 | 10,000 | — | $0 | 710,590 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2019-02-26 | 2019-02-27 | 3,887 | $33.92 | $131.8K | 706,703 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2019-02-21 | 2019-02-25 | 121,000 | — | $0 | 121,000 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2019-02-21 | 2019-02-25 | 129,600 | — | $0 | 129,600 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2019-02-21 | 2019-02-25 | 382,200 | — | $0 | 382,200 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-02-17 | 2019-02-19 | 8,750 | — | $0 | 17,500 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2019-02-17 | 2019-02-19 | 2,573 | $32.54 | $83.7K | 700,590 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-02-17 | 2019-02-19 | 8,750 | — | $0 | 703,163 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2019-02-16 | 2019-02-19 | 18,125 | — | $0 | 54,375 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2019-02-16 | 2019-02-19 | 18,125 | — | $0 | 699,753 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2019-02-16 | 2019-02-19 | 5,340 | $32.54 | $173.8K | 694,413 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2019-01-25 | 2019-01-29 | 7,500 | — | $0 | 7,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2019-01-25 | 2019-01-29 | 1,250 | — | $0 | 32,500 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2018-12-07 | 2018-12-11 | 12,224 | $34.01 | $415.7K | 681,628 | SEC↗ |
| ALKS Alkermes plc. | A Award | 2018-12-07 | 2018-12-11 | 27,500 | — | $0 | 693,852 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2018-11-26 | 2018-11-27 | 4,124 | $91.37 | $376.8K | 29,512 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2018-11-12 | 2018-11-13 | 4,123 | $103.30 | $425.9K | 33,636 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2018-10-29 | 2018-10-30 | 5,500 | $107.13 | $589.2K | 37,759 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2018-05-24 | 2018-05-25 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2018-05-22 | 2018-05-24 | 20,000 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2018-05-22 | 2018-05-24 | 20,000 | $12.29 | $245.8K | 686,352 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2018-05-22 | 2018-05-24 | 16,318 | $45.33 | $739.7K | 670,034 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2018-05-22 | 2018-05-24 | 3,682 | $46.03 | $169.5K | 666,352 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2018-05-18 | 2018-05-31 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2018-05-15 | 2018-05-17 | 50,000 | — | $0 | 20,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2018-05-15 | 2018-05-17 | 50,000 | $12.29 | $614.5K | 716,352 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2018-05-15 | 2018-05-17 | 50,000 | $46.38 | $2.32M | 666,352 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2018-05-08 | 2018-05-10 | 50,000 | — | $0 | 70,000 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2018-05-08 | 2018-05-10 | 7,360 | $44.55 | $327.9K | 666,352 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2018-05-08 | 2018-05-10 | 42,640 | $44.28 | $1.89M | 673,712 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2018-05-08 | 2018-05-10 | 50,000 | $12.29 | $614.5K | 716,352 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2018-05-01 | 2018-05-03 | 50,000 | — | $0 | 120,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2018-05-01 | 2018-05-03 | 15,000 | $7.05 | $105.8K | 0 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2018-05-01 | 2018-05-03 | 49,100 | $44.01 | $2.16M | 667,252 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2018-05-01 | 2018-05-03 | 900 | $44.66 | $40.2K | 666,352 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2018-05-01 | 2018-05-03 | 50,000 | $12.29 | $614.5K | 716,352 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2018-05-01 | 2018-05-03 | 1,253 | $84.39 | $105.7K | 43,259 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2018-05-01 | 2018-05-03 | 15,000 | $7.05 | $105.8K | 44,512 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2018-03-06 | 2018-03-08 | 37,500 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-03-06 | 2018-03-08 | 2,902 | $42.32 | $122.8K | 31,250 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-03-06 | 2018-03-08 | 34,598 | $41.34 | $1.43M | 34,152 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2018-03-06 | 2018-03-08 | 37,500 | $5.08 | $190.5K | 68,750 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2018-03-03 | 2018-03-05 | 13,000 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2018-03-03 | 2018-03-05 | 5,779 | $60.05 | $347.0K | 666,352 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2018-03-03 | 2018-03-05 | 13,000 | — | $0 | 672,131 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2018-03-01 | 2018-03-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2018-03-01 | 2018-03-05 | 17,500 | — | $0 | 35,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2018-03-01 | 2018-03-05 | 1,250 | — | $0 | 31,250 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2018-03-01 | 2018-03-05 | 17,500 | — | $0 | 666,910 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2018-03-01 | 2018-03-05 | 7,779 | $57.41 | $446.6K | 659,131 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2018-02-26 | 2018-02-28 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2018-02-26 | 2018-02-28 | 10,000 | — | $0 | 653,855 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2018-02-26 | 2018-02-28 | 4,445 | $58.12 | $258.3K | 649,410 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2018-02-17 | 2018-02-21 | 8,750 | — | $0 | 26,250 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2018-02-17 | 2018-02-21 | 8,750 | — | $0 | 646,436 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2018-02-17 | 2018-02-21 | 2,581 | $67.26 | $173.6K | 643,855 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2018-02-16 | 2018-02-21 | 72,500 | — | $0 | 72,500 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2018-02-16 | 2018-02-21 | 295,000 | — | $0 | 295,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2017-11-02 | 2017-11-03 | 50,000 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2017-11-02 | 2017-11-03 | 50,000 | $48.87 | $2.44M | 637,686 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2017-11-02 | 2017-11-03 | 50,000 | $14.13 | $706.5K | 687,686 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2017-06-22 | 2017-06-26 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2017-05-28 | 2017-05-30 | 13,750 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2017-05-28 | 2017-05-30 | 6,470 | $57.70 | $373.3K | 637,686 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2017-05-28 | 2017-05-30 | 13,750 | — | $0 | 644,156 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2017-05-24 | 2017-05-25 | 6,269 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2017-05-24 | 2017-05-25 | 18,731 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2017-05-24 | 2017-05-25 | 6,269 | $15.95 | $100.0K | 655,406 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2017-05-24 | 2017-05-25 | 25,000 | $57.42 | $1.44M | 630,406 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2017-05-24 | 2017-05-25 | 18,731 | $15.95 | $298.8K | 649,137 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2017-05-22 | 2017-06-08 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2017-05-17 | 2017-05-19 | 50,000 | — | $0 | 18,731 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2017-05-17 | 2017-05-19 | 5,939 | $59.06 | $350.8K | 630,406 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2017-05-17 | 2017-05-19 | 32,406 | $58.37 | $1.89M | 636,345 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2017-05-17 | 2017-05-19 | 11,655 | $57.23 | $667.0K | 668,751 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2017-05-17 | 2017-05-19 | 50,000 | $15.95 | $797.5K | 680,406 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2017-05-10 | 2017-05-11 | 25,000 | — | $0 | 68,731 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2017-05-10 | 2017-05-11 | 25,000 | $15.95 | $398.8K | 655,406 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2017-05-10 | 2017-05-11 | 17,159 | $57.12 | $980.1K | 638,247 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2017-05-10 | 2017-05-11 | 7,841 | $57.67 | $452.2K | 630,406 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2017-05-03 | 2017-05-05 | 15,000 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2017-05-03 | 2017-05-05 | 15,000 | $3.40 | $51.0K | 30,454 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2017-05-03 | 2017-05-05 | 952 | $53.37 | $50.8K | 29,512 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2017-03-03 | 2017-03-06 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2017-03-03 | 2017-03-06 | 6,117 | $60.97 | $373.0K | 630,406 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2017-03-03 | 2017-03-06 | 13,000 | — | $0 | 636,523 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2017-03-02 | 2017-03-14 | 7,500 | — | $0 | 7,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2017-03-02 | 2017-03-14 | 1,250 | — | $0 | 30,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2017-03-01 | 2017-03-02 | 17,500 | — | $0 | 52,500 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2017-03-01 | 2017-03-02 | 8,234 | $59.71 | $491.7K | 623,523 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2017-03-01 | 2017-03-02 | 17,500 | — | $0 | 631,757 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2017-02-26 | 2017-02-27 | 10,000 | — | $0 | 20,000 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2017-02-26 | 2017-02-27 | 4,705 | $52.98 | $249.3K | 614,257 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2017-02-26 | 2017-02-27 | 10,000 | — | $0 | 618,962 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2017-02-17 | 2017-02-21 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ALKS Alkermes plc. | A Award deriv | 2017-02-17 | 2017-02-21 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-11-29 | 2016-11-30 | 30,000 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2016-11-29 | 2016-11-30 | 27,950 | $56.93 | $1.59M | 611,012 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2016-11-29 | 2016-11-30 | 2,050 | $57.72 | $118.3K | 608,962 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-11-29 | 2016-11-30 | 30,000 | $14.38 | $431.4K | 638,962 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-11-22 | 2016-11-22 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2016-11-22 | 2016-11-22 | 23,115 | $58.43 | $1.35M | 615,847 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2016-11-22 | 2016-11-22 | 6,885 | $59.44 | $409.2K | 608,962 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-11-22 | 2016-11-22 | 30,000 | $14.38 | $431.4K | 638,962 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-11-15 | 2016-11-17 | 30,000 | — | $0 | 60,000 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2016-11-15 | 2016-11-17 | 2,060 | $59.29 | $122.1K | 608,962 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2016-11-15 | 2016-11-17 | 27,940 | $58.78 | $1.64M | 611,022 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-11-15 | 2016-11-17 | 30,000 | $14.38 | $431.4K | 638,962 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-11-08 | 2016-11-10 | 30,000 | — | $0 | 90,000 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-11-08 | 2016-11-10 | 30,000 | $14.38 | $431.4K | 638,962 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2016-11-08 | 2016-11-10 | 8,946 | $53.82 | $481.5K | 608,962 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2016-11-08 | 2016-11-10 | 21,054 | $53.05 | $1.12M | 617,908 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-10-05 | 2016-10-07 | 20,000 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | F Tax w/h | 2016-10-05 | 2016-10-07 | 9,410 | $46.43 | $436.9K | 608,962 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-10-05 | 2016-10-07 | 20,000 | — | $0 | 618,372 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-05-28 | 2016-06-01 | 13,750 | — | $0 | 13,750 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-05-28 | 2016-06-01 | 13,750 | — | $0 | 598,372 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2016-05-25 | 2016-05-26 | 15,000 | $46.72 | $700.8K | 15,464 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-05-21 | 2016-05-23 | 8,125 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-05-21 | 2016-05-23 | 8,125 | — | $0 | 584,622 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2016-05-20 | 2016-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| EPZM Epizyme, Inc. | A Award deriv | 2016-05-19 | 2016-05-23 | 12,500 | — | $0 | 12,500 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2016-05-16 | 2016-05-18 | 15,000 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2016-05-16 | 2016-05-18 | 15,000 | $3.07 | $46.0K | 31,472 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2016-05-16 | 2016-05-18 | 1,008 | $45.64 | $46.0K | 30,464 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-04-19 | 2016-04-20 | 18,750 | — | $0 | 0 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2016-04-19 | 2016-04-20 | 18,750 | $40.15 | $752.8K | 576,497 | SEC↗ |
| ALKS Alkermes plc. | M Exercise | 2016-04-19 | 2016-04-20 | 18,750 | $20.79 | $389.8K | 595,247 | SEC↗ |
| ALKS Alkermes plc. | M Exercise deriv | 2016-04-12 | 2016-04-13 | 25,000 | — | $0 | 18,750 | SEC↗ |
| ALKS Alkermes plc. | S Sale | 2016-04-12 | 2016-04-13 | 1,700 | $38.24 | $65.0K | 576,497 | SEC↗ |